DGCA weighs annual random drug tests for all commercial pilots
India’s aviation regulator is consulting on annual random psychoactive-substance testing for every commercial pilot, potentially replacing the current 10% minimum coverage. The move would materially increase compliance, lab capacity and crew-scheduling needs for airlines including Air India and IndiGo.
What happened
India’s DGCA is considering random annual psychoactive-substance testing for every commercial pilot, up from 10% minimum coverage. The proposal follows an Air
Key facts
- Over 12,000 commercial pilots could be tested annually
- Current DGCA minimum is 10% of flight crew annually
- Universal testing would represent a 10-fold increase
- About 25,000 licensed commercial pilots in India
- Air India group testing roughly 5,000 pilots
- IndiGo tests about 20% of its 5,500 pilots annually
- Air India A320neo lost about 300 feet of altitude on 4 August
- Pilot federation proposes increasing coverage to 20-25%
Why this matters
The mandate could create partnership or acquisition opportunities in aviation-focused diagnostics, sample logistics and crew-compliance software as airlines seek scalable testing infrastructure.